earnings
confidence high
sentiment positive
materiality 0.70
Biotricity Q2 FY2025 revenue up 13% YoY to $3.3M; net loss down 57% to $1.65M
BIOTRICITY INC.
2025-Q2 EPS reported
-$0.47
revenue$6,468,589
- Revenue $3.3M (+13% YoY); gross margin improved to 75.3% from 69.1%.
- Net loss decreased 57% to $1.65M ($0.073/share) from $3.88M in Q2 FY24.
- Recurring tech fees $3.06M (+12.2%), 94% of total revenue; flat fee portion up 34%.
- Achieved positive cash flow on current operating basis in September; expects continued improvement.
- SG&A cut 35.5% to $2.25M; total operating expenses down 34% YoY.